GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway.
Saved in:
| Title: | GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway. |
|---|---|
| Authors: | Xu Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Li Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Cheng Z; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China.; College of Pharmacy, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China., Shao C; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Zhao X; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Liu Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Gou X; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Li C; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2026 May 12; Vol. 20, pp. 585989. Date of Electronic Publication: 2026 May 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1177-8881 |
|---|---|
| DOI: | 10.2147/DDDT.S585989 |
